Table 2

Adjusted hazard ratios for fatal or first non-fatal cardiovascular events within five years in study population, according to sex. Data are adjusted hazard ratio (95% confidence interval)

Predictors for cardiovascular diseaseWomen (model 1)Men (model 1)
Age group (years)
 <400.25 (0.23 to 0.28)0.22 (0.20 to 0.24)
 40-4911
 50-591.86 (1.73 to 1.99)2.01 (1.90 to 2.12)
 60-693.64 (3.39 to 3.90)3.25 (3.08 to 3.43)
 70-797.62 (7.09 to 8.18)5.78 (5.46 to 6.12)
Ethnic origin
 Māori1.79 (1.69 to 1.90)1.59 (1.51 to 1.68)
 New Zealand European11
 Pacific Island1.29 (1.21 to 1.38)1.18 (1.11 to 1.25)
 Indian1.00 (0.92 to 1.10)1.25 (1.17 to 1.34)
 Chinese0.61 (0.55 to 0.68)0.53 (0.48 to 0.58)
 Other *0.74 (0.67 to 0.82)0.73 (0.67 to 0.79)
Socioeconomic deprivation group, divided by quintile
(NZDep, per quintile)
1.11 (1.09 to 1.13)1.10 (1.09 to 1.11)
Diabetes1.91 (1.79 to 2.04)1.95 (1.84 to 2.07)
Atrial fibrillation †2.04 (1.84 to 2.26)1.50 (1.38 to 1.63)
Dispensing of drug treatment ‡
 Blood pressure lowering1.85 (1.77 to 1.95)1.53 (1.46 to 1.59)
 Lipid lowering0.93 (0.88 to 0.97)0.95 (0.91 to 0.99)
 Antiplatelet1.28 (1.21 to 1.35)1.18 (1.13 to 1.24)
 Anticoagulation1.40 (1.23 to 1.60)1.43 (1.29 to 1.57)
Gout1.34 (1.23 to 1.45)1.18 (1.12 to 1.24)
  • Model 1=Cox proportional hazards model for fatal or first non-fatal cardiovascular events adjusted for age; ethnic origin; level of socioeconomic deprivation; history of diabetes; hospital admission for atrial fibrillation; and dispensing of blood pressure lowering, lipid lowering, antiplatelet or anticoagulant drug treatments; plus the additional variable of defined gout.

  • *Includes non-Chinese and non-Indian Asian, Middle Eastern, Latin American, African, and others not specified.

  • †Admission to hospital for atrial fibrillation (primary or secondary diagnosis).

  • ‡Dispensing of drugs at least once in the previous six months before 1 January 2012.